APT ALPHA PRO TECH LTD
Orthopedic, Prosthetic & Surgical Appliances & Supplies · NYSE · SEC CIK 884269 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY7.8%
TTM net income YoY40.0%
TTM EPS YoY44.1%
Revenue 3-yr CAGR3.1%
Net income 3-yr CAGR11.7%
Margins
Gross margin38.6%
Operating margin8.7%
Net margin8.1%
FCF margin14.2%
EBITDA margin10.2%
Returns
ROE8.0%
ROA6.7%
ROIC (approx.)10.2%
Asset turnover0.83x
Leverage & solvency
Liabilities / assets17.2%
Debt / equity0.00x
Current ratio8.71x
Interest coverage—
Cash quality & payout
Operating cash flow / net income1.87x
Accruals ratio-5.9%
Payout ratio—
Capex / revenue1.0%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 | FY20232023-12-31 | FY20222022-12-31 | FY20212021-12-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $59.14M | $57.84M | $61.23M | $61.98M | $68.64M |
| Cost of revenue | $36.60M | $34.91M | $38.40M | $40.30M | $43.34M |
| Gross profit | $22.54M | $22.93M | $22.83M | $21.68M | $25.30M |
| SG&A expense | $17.77M | $18.61M | $17.77M | $16.22M | $16.55M |
| Operating income | $3.84M | $3.45M | $4.13M | $4.65M | $7.93M |
| Income tax | $1.14M | $1.09M | $1.24M | $1.11M | $1.74M |
| Net income | $3.53M | $3.93M | $4.19M | $3.28M | $6.76M |
| EBITDA | $4.76M | $4.32M | $5.06M | $5.46M | $8.74M |
| EPS (basic) | 0.34 | 0.35 | 0.35 | 0.26 | 0.51 |
| EPS (diluted) | 0.33 | 0.35 | 0.35 | 0.26 | 0.50 |
| Weighted avg. shares (diluted) | 10.55M | 11.24M | 11.86M | 12.78M | 13.50M |
| Balance sheet | |||||
| Cash & equivalents | $16.99M | $18.64M | $20.38M | $16.29M | $16.31M |
| Receivables | — | — | — | $5.38M | $3.40M |
| Inventory | $23.60M | $22.73M | $20.13M | $24.40M | $24.97M |
| Current assets | $52.52M | $50.64M | $53.06M | $52.56M | $53.00M |
| PP&E, net | $8.23M | $8.52M | $5.59M | $5.74M | $6.06M |
| Goodwill | $55,000 | $55,000 | $55,000 | $55,000 | $55,000 |
| Intangibles | — | — | $0 | $1,000 | $3,000 |
| Total assets | $74.13M | $73.74M | $68.76M | $64.80M | $67.02M |
| Current liabilities | $4.06M | $3.12M | $2.57M | $2.41M | $2.66M |
| Total liabilities | $11.65M | $11.51M | $7.20M | $4.04M | $5.27M |
| Shareholders' equity | $62.48M | $62.23M | $61.57M | $60.76M | $61.75M |
| Shares outstanding | 10.13M | 10.82M | 11.42M | 12.23M | 13.12M |
| Cash flow statement | |||||
| Operating cash flow | $2.37M | $5.70M | $8.46M | $4.28M | -$480,000 |
| Capital expenditure | $639,000 | $3.81M | $792,000 | $492,000 | $2.52M |
| Free cash flow | $1.73M | $1.89M | $7.67M | $3.79M | -$3.00M |
| Investing cash flow | -$639,000 | -$3.78M | -$792,000 | — | -$2.52M |
| Financing cash flow | -$3.38M | -$3.66M | -$3.58M | -$3.80M | -$3.98M |
| Depreciation & amortization | $925,000 | $873,000 | $925,000 | $814,000 | $817,000 |
| Stock-based compensation | $540,000 | $463,000 | $170,000 | $147,000 | $315,000 |
| Share buybacks | $3.35M | $4.45M | $4.00M | $3.88M | $4.41M |
Free plan shows the latest 5 periods; Pro shows all 16 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.